Treatment challenges in a 25-year-old female with bipolar disorder and social phobia: A case study

INTRODUCTION

Bipolar disorder (BD) represents a complex mood disorder characterized by alternating episodes of depression and mania or hypomania, often with inter-episode symptoms that significantly impact functioning and quality of life.¹ The Diagnostic and Statistical Manual of Mental Disorders, 5, Text Revision (DSM-5-TR) defines bipolar I disorder as the occurrence of at least one manic episode, potentially preceded or followed by hypomanic or major depressive episodes, with mania lasting at least 1 week and including elevated or irritable mood plus three or more additional symptoms such as grandiosity, decreased need for sleep, and pressured speech.² Bipolar II disorder, on the other hand, is diagnosed based on at least one hypomanic episode and one major depressive episode, without any history of full manic episodes.³ Similarly, the International Classification of Diseases - 11 (ICD-11) defines BD s by the presence of episodic mood elevation (mania or hypomania) typically alternating with depressive episodes, with significant impairment in functioning or distress.⁴

The lifetime prevalence of bipolar spectrum disorders is approximately 2.4%, with bipolar II disorder accounting for 0.3%–1.1%.⁵ Onset frequently occurs in late adolescence or early adulthood, a critical period for educational achievement and psychosocial development.⁶

Comorbidity in BD is common, with anxiety disorders being among the most frequent concurrent conditions. Approximately 50%–75% of individuals with BD have at least one comorbid anxiety disorder during their lifetime.⁷ Social anxiety disorder (SAD), specifically, affects approximately 20% of bipolar patients and often complicates clinical presentation and treatment outcomes.⁸

The accurate diagnosis and effective management of BD with comorbid conditions remain challenging. Treatment resistance occurs in approximately 30% of bipolar patients, particularly when comorbidities are present.⁹ The complexity increases in young adults, where developmental factors, educational pursuits, and emerging social roles intersect with illness manifestations.¹⁰ According to the DSM-5-TR, SAD is characterized by persistent fear or anxiety in social or performance situations where scrutiny by others may occur, lasting 6 months or longer, with significant impact on daily functioning.² The ICD-11 also describes SAD as a persistent and excessive fear of being observed or evaluated negatively, leading to avoidance of social interactions and marked functional impairment.³

This case study explores the clinical presentation, diagnostic journey, and treatment challenges of a 25-year-old female with bipolar II disorder comorbid with social phobia. The case illustrates the difficulties in achieving symptom remission despite multiple medication trials and highlights the importance of a comprehensive treatment approach.

CASE REPORT

DISCUSSION

This study illustrates several important clinical considerations in the management of BD with comorbid social anxiety. The case presentation aligns with current literature, indicating that bipolar II disorder often has an insidious onset in late adolescence, with depressive episodes typically preceding hypomanic episodes.¹¹ Her initial misdiagnosis as having unipolar depression is common, with studies suggesting diagnostic delays of 5–10 years from symptom onset to a correct bipolar diagnosis.¹²

The patient’s comorbid social anxiety significantly complicated her clinical presentation and treatment. Research indicates that anxiety comorbidity in BD is associated with greater illness severity, increased suicide risk, poorer treatment response, and worse functional outcomes.¹³ Figure 1 illustrates the relationship between comorbid anxiety disorders and clinical outcomes in BD.

Close

Figure 1:

Impact of anxiety comorbidity on clinical outcomes in BD. The figure illustrates how the presence of comorbid anxiety disorders contributes to increased symptom severity, treatment resistance, functional impairment, and reduced quality of life in patients with BD. BD: Bipolar disorder.

Export to PPT

The patient’s treatment journey highlights the challenges in pharmacological management of BD with anxiety comorbidity. Antidepressant use in BD remains controversial, with concerns about potential mood destabilization and cycle acceleration.¹⁴ In this case, the use of fluoxetine may have contributed to hypomanic episodes, necessitating mood stabilizer introduction. The current combination of valproic acid and sertraline represents an attempt to address both bipolar symptoms and anxiety, though evidence for this specific combination is limited.¹⁵

The patient’s partial treatment response underscores the importance of comprehensive psychosocial interventions alongside pharmacotherapy. Figure 2 presents an integrated treatment approach for BD with comorbid anxiety.

Close

Figure 2:

Integrated treatment approach for BD with comorbid anxiety. The figure displays a comprehensive model combining pharmacotherapy, psychotherapy, psychoeducation, and functional rehabilitation, highlighting the multidimensional approach required for optimal treatment outcomes. BD: Bipolar disorder.

Export to PPT

Psychoeducation is particularly important for this patient to improve illness understanding and treatment adherence.¹⁶ Cognitive-behavioral therapy specifically targeting both bipolar symptoms and social anxiety could address cognitive distortions, social avoidance, and emotion regulation difficulties.¹⁷ Family involvement is crucial given the patient’s living situation and apparent functional dependence.

This case also highlights the impact of BD on educational and occupational functioning in young adults. Despite completing an engineering degree, the patient remained unemployed due to her psychiatric symptoms. Vocational rehabilitation and supported employment programs have shown promise for individuals with serious mental illness and should be emphasized in the treatment plan.¹⁸

CONCLUSION

This case study illustrates the complex clinical presentation and treatment challenges of bipolar II disorder with comorbid social phobia in a young adult female. Despite multiple medication trials over 5 years, the patient experienced persistent symptoms affecting her social functioning and occupational capacity. This case emphasizes the importance of accurate diagnosis, comprehensive assessment of comorbidities, and an integrated treatment approach combining appropriate pharmacotherapy with targeted psychosocial interventions.

The treatment recommendations, including psychoeducation, group and individual psychotherapy, family therapy, and vocational rehabilitation, align with current evidence-based approaches for complex presentations of BD. Long-term management should focus not only on symptom stabilization but also on functional recovery and quality of life improvement.

Future research should address optimal treatment strategies for BD with anxiety comorbidities, particularly regarding antidepressant use and specific psychotherapeutic approaches for this population.